EuroPCR 2022

18 May 2022

Stents, scaffolds and DCB

The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms

Sponsored by Concept Medical Inc.

Anchorperson: A. Abizaid

Moderator: M. Valgimigli

SHOW MORE

Summary

Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features that could change daily practice and improve outcomes.

Learning Objectives

To find out more about the application and mechanism of a sirolimus coated balloon for coronary artery disease treatment with case presentations in complex settings
To understand how useful is a DES and DCB stent platform in complex coronary artery disease settings with case demonstrations and follow-up in diabetes mellitus
To look at the technology behind the products, what the key data suggest and important takeaways from case permutations

Speaker

Session objectives

Download presentation

Speaker

Experience with Abluminus DES+: pre-procedure and cases from ABILITY Diabetes Global

Download presentation

Luca Testa

Speaker

OCT and angio follow-up with the Abluminus DES+: cases from the Ability randomised clinical trial

Download presentation

Prof. Patrick W. Serruys

Speaker

Introduction of MagicTouch - Mechanism of balloon angioplasty in the era of drug-coated balloon

Download presentation

Sandeep Basavarajaiah

Speaker

S. Basavarajaiah

Long term follow-up - Case and remodeling MagicTouch SCB

Download presentation

Marco Valgimigli

Speaker

Key takeaways - Learnings and data for MagicTouch SCB and Abluminus DES

Download presentation